Bloomberg News has hired Amber Tong as an Asia pharmaceuticals reporter based in Hong Kong.
She previously was an Endpoints News senior editor.
In addition to writing on the biggest scientific and business updates of the day, she steered coverage decisions for the newsroom and set the agenda before the U.S. and Europe are awake. She has a particular focus on oncology, and how technologies developed for cancer are being used in other diseases.
Tong is a graduate of Rice University with a degree in anthropology.
